Literature DB >> 9220551

Amelanotic malignant melanoma.

M J Adler1, C R White.   

Abstract

Amelanotic malignant melanoma (AMM) often defies clinical diagnosis because of its wide range of clinical appearances and lack of pigmentation. Biopsy of AMM typically yields the correct diagnosis, although the histological findings, especially in metastatic lesions, occasionally may be confused with other malignancies. In cases histologically challenging, immunohistochemical techniques frequently provide diagnostic information. Multiple mechanisms to explain amelanosis have been suggested, all resulting in a single, common amelanotic phenotype. Appropriate studies to compare outcomes of amelanotic versus pigmented melanomas have not been performed. Treatment recommendations for AMM are identical to those for pigmented melanomas, although accurately defining clinical margins of the neoplasm often is challenging. Overall, a high index of suspicion and a low threshold to biopsy unusual clinical lesions ultimately may allow for earlier diagnosis and treatment of these frequently lethal malignancies.

Entities:  

Mesh:

Year:  1997        PMID: 9220551     DOI: 10.1016/s1085-5629(97)80006-5

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  12 in total

1.  [Two rarely seen manifestations of malignant melanoma].

Authors:  V von Felbert; F Abuzahra
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

2.  Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences.

Authors:  Susannah E McClain; Kira B Mayo; Amber L Shada; Mark E Smolkin; James W Patterson; Craig L Slingluff
Journal:  Int J Dermatol       Date:  2012-04       Impact factor: 2.736

3.  Different levels of TGFbeta, IL-10, IFNgamma and gelatinase A occur in experimental white and black metastases induced by bryostatin 1 or by phorbol ester-treated BL6T murine melanoma cells.

Authors:  C A La Porta; R Comolli
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway.

Authors:  L Bizzozero; D Cazzato; D Cervia; E Assi; F Simbari; F Pagni; C De Palma; A Monno; C Verdelli; P R Querini; V Russo; E Clementi; C Perrotta
Journal:  Cell Death Differ       Date:  2013-12-06       Impact factor: 15.828

5.  Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.

Authors:  Lihui Wei; Yubin Miao; Fabio Gallazzi; Thomas P Quinn; Michael J Welch; Amy L Vāvere; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2007-09-04       Impact factor: 2.408

6.  Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

Authors:  Nancy E Thomas; Anne Kricker; Weston T Waxweiler; Patrick M Dillon; Klaus J Busman; Lynn From; Pamela A Groben; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Alison Venn; Peter A Kanetsky; Irene Orlow; Susan Paine; David W Ollila; Anne S Reiner; Li Luo; Honglin Hao; Jill S Frank; Colin B Begg; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2014-12       Impact factor: 10.282

7.  Red Nodule in a Post-surgical Scar: A Quiz.

Authors:  Piotr K Krajewski; Iwona Chlebicka; Kinga Tyczyńska; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2020-06-15       Impact factor: 3.875

Review 8.  Anorectal mucosal melanoma.

Authors:  Giulia Malaguarnera; Roberto Madeddu; Vito Emanuele Catania; Gaetano Bertino; Luca Morelli; Rosario Emanuele Perrotta; Filippo Drago; Michele Malaguarnera; Saverio Latteri
Journal:  Oncotarget       Date:  2018-01-02

9.  Amelanotic Malignant Melanoma with a BRAF V600E Mutation Mimicking Primary Lung Cancer.

Authors:  Reiko Matsuzawa; Masahiro Morise; Ichidai Tanaka; Shunsaku Hayai; Yutaro Tamiya; Junji Koyama; Tetsunari Hase; Keiko Wakahara; Deoksu Kim; Yoshie Shimoyama; Naozumi Hashimoto
Journal:  Intern Med       Date:  2021-08-24       Impact factor: 1.271

10.  Relearning the lesson -- amelanotic malignant melanoma: a case report.

Authors:  Ezekiel Oburu; Alberto Gregori
Journal:  J Med Case Rep       Date:  2008-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.